These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 7060318

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Bioavailability of Theodel, a new theophylline tablet, in humans.
    Rovei V, Strolin Benedetti M, Donath A, Grenot C, Chanoine F.
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):425-30. PubMed ID: 6629546
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Pharmacokinetics of theophylline and 3-methylxanthine in guinea pigs. I. Single dose administration.
    Madsen SM, Ribel U.
    Acta Pharmacol Toxicol (Copenh); 1981 Jan; 48(1):1-7. PubMed ID: 7223434
    [Abstract] [Full Text] [Related]

  • 27. Effects of alpha-interferon on theophylline pharmacokinetics and metabolism.
    Jonkman JH, Nicholson KG, Farrow PR, Eckert M, Grasmeijer G, Oosterhuis B, De Noord OE, Guentert TW.
    Br J Clin Pharmacol; 1989 Jun; 27(6):795-802. PubMed ID: 2757895
    [Abstract] [Full Text] [Related]

  • 28. Temporal variation in the disposition of theophylline and its metabolites.
    St-Pierre MV, Spino M, Isles AF, Tesoro A, MacLeod SM.
    Clin Pharmacol Ther; 1985 Jul; 38(1):89-95. PubMed ID: 4039998
    [Abstract] [Full Text] [Related]

  • 29. Depression of theophylline elimination by erythromycin.
    Renton KW, Gray JD, Hung OR.
    Clin Pharmacol Ther; 1981 Sep; 30(3):422-6. PubMed ID: 7273607
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pharmacokinetics of theophylline and 3-methylxanthine in guinea pigs. II. Multiple dose administration.
    Madsen SM, Ribel U.
    Acta Pharmacol Toxicol (Copenh); 1981 Jan; 48(1):8-12. PubMed ID: 7223441
    [Abstract] [Full Text] [Related]

  • 35. 1-Methylxanthine derived from theophylline as an in vivo biochemical probe of allopurinol effect.
    Birkett DJ, Miners JO, Day RO.
    Br J Clin Pharmacol; 1991 Aug; 32(2):238-41. PubMed ID: 1931474
    [Abstract] [Full Text] [Related]

  • 36. Effects of lansoprazole on pharmacokinetics and metabolism of theophylline.
    Kokufu T, Ihara N, Sugioka N, Koyama H, Ohta T, Mori S, Nakajima K.
    Eur J Clin Pharmacol; 1995 Aug; 48(5):391-5. PubMed ID: 8641328
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effect of decursinol angelate on the pharmacokinetics of theophylline and its metabolites in rats.
    Chae JW, An JH, Kang W, Ma Jy, Kwon KI.
    Food Chem Toxicol; 2012 Oct; 50(10):3666-72. PubMed ID: 22771369
    [Abstract] [Full Text] [Related]

  • 39. Theophylline pharmacokinetics in normal elderly subjects.
    Shin SG, Juan D, Rammohan M.
    Clin Pharmacol Ther; 1988 Nov; 44(5):522-30. PubMed ID: 3180633
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.